Results 281 to 290 of about 4,329,929 (348)
Some of the next articles are maybe not open access.

Antibody and antibody fragments for cancer immunotherapy

Journal of Controlled Release, 2020
Antibody has become the most rapidly expanding class of pharmaceuticals for treating a wide variety of human diseases including cancers. Especially, with the fast development of cancer immunotherapy, antibody drugs have become the most promising therapeutic for curing cancers.
Weizhi Chen, Yang Yuan, Xiqun Jiang
openaire   +2 more sources

Phage antibodies: will new ‘coliclonal’ antibodies replace monoclonal antibodies?

Trends in Biotechnology, 1992
Antibodies can now be rapidly isolated from large and diverse recombinant libraries by displaying functional antibody fragments on the surface of bacteriophage particles and directly selecting with antigen. This method has been used to isolate antibodies, including human antibodies, with and without immunization, and to improve the affinity and ...
D J, Chiswell, J, McCafferty
openaire   +2 more sources

Antibodies in proteomics I: generating antibodies

Trends in Biotechnology, 2003
The explosion in genome sequencing, and in subsequent DNA array experiments, has provided extensive information on gene sequence, organization and expression. This has resulted in a desire to perform similarly broad experiments on all the proteins encoded by a genome.
BRADBURY A.   +9 more
openaire   +3 more sources

Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in Oncohematology

Recent Patents on Anti-Cancer Drug Discovery, 2020
Background: The therapeutic outcomes and the prognosis of patients with various hematologic malignancies are not always ideal with the current standard of care. Objective: The aim of this study is to analyze the results of the use of monoclonal antibodies, bispecific antibodies and antibody-drug conjugates for the therapy of malignant hemopathies.
openaire   +2 more sources

Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Journal of Immunology, 1972
A sensitive and simple method for the quantitative determination of antibodies is reported. Tubes coated with antigen are incubated with antiserum followed by an enzyme-labeled preparation of anti-immunoglobulin. The enzyme remaining in the tubes after
E. Engvall, P. Perlmann
semanticscholar   +1 more source

Antibody and antibody derivatives as cancer therapeutics

WIREs Nanomedicine and Nanobiotechnology, 2019
Antibodies are an important class of therapeutic for treating a wide range of diseases. These versatile macromolecules can be engineered to target many different antigens and to utilize several mechanisms of action to produce a pharmacological effect. The most common antibody platform used for therapeutics is immunoglobulin G (IgG). Advances in protein‐
Keith J, Arlotta, Shawn C, Owen
openaire   +2 more sources

Antiphospholipid antibody and antiphospholipid antibody syndrome

Current Opinion in Rheumatology, 1991
New details have been added to the description of the antiphospholipid antibody syndrome. These include quantitation of risk of stroke; delineation of an associated acute occlusive vasculopathy syndrome, including its pathology; increased awareness of the association of adrenal insufficiency with antiphospholipid antibody; new demonstration of ...
openaire   +2 more sources

Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

Journal of Clinical Endocrinology and Metabolism, 2002
J. Hollowell   +6 more
semanticscholar   +1 more source

ANTIBODIES

2021
KOOPMAN LOUISE   +8 more
openaire   +6 more sources

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Shanu Modi   +2 more
exaly  

Home - About - Disclaimer - Privacy